Published in Arch Intern Med on August 16, 2007
Observational Trial on Cytokine Adsorption in Sepsis (OuTCASt) | NCT04306419
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int (2009) 2.97
Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest (2009) 2.71
Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA (2015) 2.53
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med (2008) 2.37
Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int (2011) 2.22
Do hospitals provide lower quality of care to black patients for pneumonia? Crit Care Med (2010) 2.07
Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A (2012) 2.05
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med (2010) 1.95
Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med (2013) 1.94
Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med (2013) 1.92
Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int (2011) 1.87
Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med (2011) 1.77
Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med (2009) 1.71
Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med (2010) 1.70
A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit Care Med (2012) 1.69
Biomarkers of sepsis. Crit Rev Clin Lab Sci (2013) 1.48
Cytokine and nitric oxide levels in patients with sepsis--temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS One (2014) 1.42
Effects of intra-abdominal sepsis on atherosclerosis in mice. Crit Care (2014) 1.34
Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis. Crit Care Med (2012) 1.33
Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One (2011) 1.32
Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med (2008) 1.32
The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax (2010) 1.31
Sepsis: Something old, something new, and a systems view. J Crit Care (2011) 1.29
Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care (2012) 1.23
Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care (2010) 1.23
The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J (2009) 1.22
Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis (2009) 1.19
Functional disability, cognitive impairment, and depression after hospitalization for pneumonia. Am J Med (2013) 1.17
Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLoS One (2011) 1.17
Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol (2012) 1.16
Proteomics reveals age-related differences in the host immune response to sepsis. J Proteome Res (2013) 1.16
Chronic medical conditions and risk of sepsis. PLoS One (2012) 1.16
Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol (2011) 1.13
Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care (2015) 1.12
Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Mol Med (2009) 1.12
Demographics, guidelines, and clinical experience in severe community-acquired pneumonia. Crit Care (2008) 1.10
Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit Care (2010) 1.09
Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care (2009) 1.07
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care (2010) 1.06
Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis (2013) 1.06
Using data-driven rules to predict mortality in severe community acquired pneumonia. PLoS One (2014) 1.06
Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice. Am J Physiol Renal Physiol (2011) 1.05
Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies. Mol Med (2012) 1.03
Relationship between acid-base status and inflammation in the critically ill. Crit Care (2014) 1.02
Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transplant (2014) 1.01
Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion. Evid Based Complement Alternat Med (2013) 1.00
Computational and systems biology in trauma and sepsis: current state and future perspectives. Int J Burns Trauma (2012) 0.99
Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis (2009) 0.99
Role of cytokines as a double-edged sword in sepsis. In Vivo (2013) 0.98
Glucocorticoids in sepsis: dissecting facts from fiction. Crit Care (2011) 0.97
Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure. Crit Care (2010) 0.97
Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study. J Crit Care (2013) 0.97
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ. BMC Pulm Med (2012) 0.97
The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One (2013) 0.96
Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study. Crit Care (2014) 0.96
A simple mathematical model of cytokine capture using a hemoadsorption device. Ann Biomed Eng (2008) 0.96
Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care (2014) 0.94
Attenuated response of aged mice to respiratory Francisella novicida is characterized by reduced cell death and absence of subsequent hypercytokinemia. PLoS One (2010) 0.93
The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation. Surg Clin North Am (2009) 0.92
Interplay between sepsis and chronic health. Trends Mol Med (2014) 0.92
The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm Med (2010) 0.92
Obesity and risk of sepsis: a population-based cohort study. Obesity (Silver Spring) (2013) 0.91
One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice. Nephrol Dial Transplant (2012) 0.91
The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Crit Care (2008) 0.90
The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS One (2010) 0.90
Risk of cardiovascular events in survivors of severe sepsis. Am J Respir Crit Care Med (2014) 0.89
Impact of vitamin D on infectious disease. Am J Med Sci (2015) 0.89
Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model. Crit Care Med (2010) 0.89
Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes. Clin J Am Soc Nephrol (2015) 0.88
Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open (2014) 0.88
Diagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical care. J Am Coll Surg (2010) 0.88
Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance. J Pharmacol Exp Ther (2011) 0.87
Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol (2011) 0.87
Use of CRB-65 and quick Sepsis-related Organ Failure Assessment to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study. Crit Care (2016) 0.87
The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients. BMJ Open (2012) 0.86
Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis--a prospective, observational study. BMC Immunol (2013) 0.86
Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness. Aging Dis (2011) 0.86
Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model. Crit Care (2014) 0.86
MMP-8 genotypes influence the inflammatory response in human endotoxemia. Inflammation (2014) 0.86
Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research? Pharmacogenomics J (2009) 0.86
Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes. Immunology (2009) 0.85
Dynamics of a cytokine storm. PLoS One (2012) 0.85
A Parametric Survival Model When a Covariate is Subject to Left-Censoring. J Biom Biostat (2012) 0.85
Cytokines and signaling molecules predict clinical outcomes in sepsis. PLoS One (2013) 0.85
Biomarkers in sepsis. Curr Opin Pulm Med (2013) 0.85
Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res (2015) 0.85
Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsis. Springerplus (2014) 0.84
IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy. J Biomed Mater Res B Appl Biomater (2010) 0.84
Flavone deglycosylation increases their anti-inflammatory activity and absorption. Mol Nutr Food Res (2012) 0.83
Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device. Ann Biomed Eng (2009) 0.83
The role of inflammation in ICU-acquired weakness. Crit Care (2010) 0.83
Pneumococcal pneumonia and the risk of stroke: a population-based follow-up study. PLoS One (2012) 0.82
SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice. J Trauma (2010) 0.82
Role of an iron-dependent transcriptional regulator in the pathogenesis and host response to infection with Streptococcus pneumoniae. PLoS One (2013) 0.82
Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care (2014) 0.82
Inhibition of serum- and glucocorticoid-inducible kinase 1 enhances TLR-mediated inflammation and promotes endotoxin-driven organ failure. FASEB J (2015) 0.82
Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol (2014) 0.81
Diagnosing sepsis - The role of laboratory medicine. Clin Chim Acta (2016) 0.81
Long term outcomes following hospital admission for sepsis using relative survival analysis: a prospective cohort study of 1,092 patients with 5 year follow up. PLoS One (2014) 0.81
Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients. Crit Care (2012) 0.81
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Random-effects models for longitudinal data. Biometrics (1982) 54.17
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med (1992) 20.79
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 19.77
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest (1991) 16.06
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med (2006) 15.04
Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78
Points of control in inflammation. Nature (2002) 10.61
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Treating patients with severe sepsis. N Engl J Med (1999) 6.56
The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med (1997) 4.98
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychol Methods (2001) 4.25
Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) Ann Intern Med (1996) 3.74
A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med (1993) 3.70
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med (2004) 3.61
Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03
Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med (2003) 3.00
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79
L-arginine pathway in the sepsis syndrome. Crit Care Med (1993) 2.37
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care (2004) 2.25
Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med (2001) 1.96
New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med (2001) 1.95
Why sepsis trials fail. JAMA (1996) 1.95
Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol (2004) 1.65
Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med (1998) 1.65
Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med (1996) 1.52
A tobit variance-component method for linkage analysis of censored trait data. Am J Hum Genet (2003) 1.49
Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med (1999) 1.40
Alterations of lipid metabolism in mice injected with endotoxin. Microbiol Immunol (1979) 1.18
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med (1994) 1.13
Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med (1994) 1.06
A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome. Intensive Care Med (2001) 0.98
Sepsis and controlled clinical trials: the odyssey continues. Crit Care Med (1995) 0.91
Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surg (1998) 0.90
A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase. Intensive Care Med (1993) 0.89
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med (2004) 9.06
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Outcomes of medical emergencies on commercial airline flights. N Engl J Med (2013) 6.29
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet (2011) 6.25
National estimates of severe sepsis in United States emergency departments. Crit Care Med (2007) 5.99
The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med (2004) 5.23
Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med (2012) 5.22
Variation in critical care services across North America and Western Europe. Crit Care Med (2008) 5.00
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med (2010) 4.41
Out-of-hospital endotracheal intubation and outcome after traumatic brain injury. Ann Emerg Med (2004) 4.33
Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA (2002) 4.09
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med (2006) 3.71
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68
Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med (2008) 3.44
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37
Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med (2004) 3.36
Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med (2012) 3.36
The epidemiology of mechanical ventilation use in the United States. Crit Care Med (2010) 3.28
Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med (2007) 3.27
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18
Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med (2007) 3.17
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
Pneumonia: still the old man's friend? Arch Intern Med (2003) 3.12
Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int (2002) 3.07
Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med (2002) 3.02
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int (2009) 2.97
HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 2.95
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med (2015) 2.92
Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med (2002) 2.91
Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA (2010) 2.87
The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med (2006) 2.84
Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry (2007) 2.80
pSAT vectors: a modular series of plasmids for autofluorescent protein tagging and expression of multiple genes in plants. Plant Mol Biol (2005) 2.75
Defining the incidence of cardiorespiratory instability in patients in step-down units using an electronic integrated monitoring system. Arch Intern Med (2008) 2.73
The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med (2012) 2.72
Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med (2013) 2.67
Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67
Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol (2009) 2.66
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50
Esophageal Doppler monitoring predicts fluid responsiveness in critically ill ventilated patients. Intensive Care Med (2005) 2.48
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med (2003) 2.44
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med (2013) 2.44
Prioritizing the organization and management of intensive care services in the United States: the PrOMIS Conference. Crit Care Med (2007) 2.42
Use of non-invasive NIRS during a vascular occlusion test to assess dynamic tissue O(2) saturation response. Intensive Care Med (2008) 2.42
Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med (2007) 2.39
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med (2008) 2.37
Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35
Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl (2004) 2.31
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med (2010) 2.31
Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med (2008) 2.31
Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30
Severe sepsis epidemiology: sampling, selection, and society. Crit Care (2004) 2.28
Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA (2010) 2.27
Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med (2006) 2.27
Perceptions of safety culture vary across the intensive care units of a single institution. Crit Care Med (2007) 2.24
The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med (2004) 2.24
Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA (2014) 2.23
Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int (2011) 2.22